Zobrazeno 1 - 10
of 19 467
pro vyhledávání: '"fms"'
Autor:
Cortes J; Georgia Cancer Center at Augusta University, 1410 Laney Walker Blvd., CN2222, Augusta, GA, 30912, USA. jorge.cortes@augusta.edu.
Publikováno v:
Journal of hematology & oncology [J Hematol Oncol] 2024 Nov 13; Vol. 17 (1), pp. 111. Date of Electronic Publication: 2024 Nov 13.
Autor:
Othman J; Department of Medical and Molecular Genetics, King's College London, London, United Kingdom.; Department of Haematology, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.; Faculty of Medicine and Health, University of Sydney, Sydney, Australia., Hwang A; Haematology, University College London Hospital NHS Foundation Trust, London, United Kingdom., Brodermann M; Haematology, University College London Hospital NHS Foundation Trust, London, United Kingdom., Abdallah I; Department of Haematology, Leeds Teaching Hospitals Trust, Leeds, United Kingdom., McCloskey K; Haematology, St Bartholomew's Hospital, Barts Health NHS Trust, London, United Kingdom., Gallipoli P; Barts Cancer Institute, Queen Mary University of London, London, United Kingdom., Clarke G; Clinical Haematology, James Cook University Hospital, Middlesbrough, United Kingdom., Dang R; Clinical Haematology, James Cook University Hospital, Middlesbrough, United Kingdom., Vidler J; Haematology, King's College Hospital, London, United Kingdom., Krishnamurthy P; Haematology, King's College Hospital, London, United Kingdom., Basheer F; Haematology, Addenbrooke's Hospital, Cambridge, United Kingdom., Latif AL; Department of Haematology, Queen Elizabeth University Hospital, Glasgow, United Kingdom., Palanicawandar R; Haematology, Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, United Kingdom., Taylor T; Department of Haematology, Nottingham University Hospital, Nottingham, United Kingdom., Khan A; Department of Clinical Haematology, Blackpool Teaching Hospitals NHS Foundation Trust, Blackpool, United Kingdom., Campbell V; Haematology Centre, Western General Hospital, Edinburgh, United Kingdom., Hogan F; Haematology Department, University Hospital of Wales, Cardiff, United Kingdom., Kanellopoulos A; Clinical Haematology, Sheffield Teaching Hospitals NHS Trust, Royal Hallamshire Hospital, Sheffield, United Kingdom., Fleming K; Bristol Haematology and Oncology Centre, University Hospital Bristol and Weston, Bristol, United Kingdom., Collins A; Haematology Department, Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich, United Kingdom., Dalley C; Haematology Department, University Hospital Southampton, Southampton, United Kingdom., Loke J; Centre for Clinical Haematology, Queen Elizabeth Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom., Marshall S; Haematology, City Hospitals Sunderland NHS Trust, Sunderland, United Kingdom., Taussig D; Haemato-oncology Unit, Royal Marsden Hospital, The Royal Marsden NHS Foundation Trust, Surrey, United Kingdom., Munisamy S; Haematology Department, East Kent Hospitals University NHS Foundation, Canterbury, United Kingdom., Loizou E; Haematology, Mersey and West Lancashire Teaching Hospitals NHS Trust, Whiston, United Kingdom., Yassin H; Haematology, University Hospitals Sussex NHS Foundation Trust, Worthing, United Kingdom., Dennis M; Haematology and Transplant Unit, The Christie NHS Foundation Trust, Manchester, United Kingdom., Zhao R; Haematology, Torbay Hospital, Torquay, United Kingdom., Belsham E; Haematology, Portsmouth Hospitals University NHS Trust, Portsmouth, United Kingdom., Murray D; Haematology, University Hospitals Coventry and Warwickshire NHS Trust, Coventry, United Kingdom., Fowler N; Haematology, Royal Cornwall Hospitals NHS Trust, Truro, United Kingdom., O'Nions J; Haematology, University College London Hospital NHS Foundation Trust, London, United Kingdom., Khan A; Department of Haematology, Leeds Teaching Hospitals Trust, Leeds, United Kingdom., Sellar R; Haematology, University College London Hospital NHS Foundation Trust, London, United Kingdom.; Department of Haematology, UCL Cancer Institute, London, United Kingdom., Dillon R; Department of Medical and Molecular Genetics, King's College London, London, United Kingdom.; Department of Haematology, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.
Publikováno v:
Blood advances [Blood Adv] 2024 Nov 12; Vol. 8 (21), pp. 5590-5597.
Autor:
Jouvenel A; Université de Montpellier, Montpellier, France.; Inserm U-1298, Institut des Neurosciences de Montpellier, Montpellier, France., Tassou A; Université de Montpellier, Montpellier, France.; Inserm U-1298, Institut des Neurosciences de Montpellier, Montpellier, France., Thouaye M; Université de Montpellier, Montpellier, France.; Inserm U-1298, Institut des Neurosciences de Montpellier, Montpellier, France., Ruel J; Centre de Recherche en CardioVasculaire et Nutrition, Aix-Marseille Université - INSERM 1263 -INRAE 1260, Marseille, France., Antri M; NeuroDol INSERM 1107, Clermont-Ferrand, France., Leyris JP; Biodol Therapeutics, 165 rue Denis Papin, Montarnaud, 34570, France., Giraudin A; NeuroDol INSERM 1107, Clermont-Ferrand, France., Mallié S; Inserm U-1298, Institut des Neurosciences de Montpellier, Montpellier, France., Sar C; Université de Montpellier, Montpellier, France.; Inserm U-1298, Institut des Neurosciences de Montpellier, Montpellier, France., Diouloufet L; Inserm U-1298, Institut des Neurosciences de Montpellier, Montpellier, France.; Biodol Therapeutics, 165 rue Denis Papin, Montarnaud, 34570, France., Sonrier C; Inserm U-1298, Institut des Neurosciences de Montpellier, Montpellier, France.; Biodol Therapeutics, 165 rue Denis Papin, Montarnaud, 34570, France., Daubeuf F; Laboratoire d'Innovation Thérapeutique, UMR7200 CNRS/Université de Strasbourg, 67400, Illkirch, France., Bertin J; Inserm U-1298, Institut des Neurosciences de Montpellier, Montpellier, France.; Biodol Therapeutics, 165 rue Denis Papin, Montarnaud, 34570, France., Alves S; Université de Montpellier, Montpellier, France.; Inserm U-1298, Institut des Neurosciences de Montpellier, Montpellier, France., Ventéo S; Université de Montpellier, Montpellier, France.; Inserm U-1298, Institut des Neurosciences de Montpellier, Montpellier, France., Frossard N; Laboratoire d'Innovation Thérapeutique, UMR7200 CNRS/Université de Strasbourg, 67400, Illkirch, France., Carroll P; Université de Montpellier, Montpellier, France.; Inserm U-1298, Institut des Neurosciences de Montpellier, Montpellier, France., Mechaly I; Université de Montpellier, Montpellier, France.; Inserm U-1298, Institut des Neurosciences de Montpellier, Montpellier, France., Rognan D; Laboratoire d'Innovation Thérapeutique, UMR7200 CNRS/Université de Strasbourg, 67400, Illkirch, France., Sokoloff P; Biodol Therapeutics, 165 rue Denis Papin, Montarnaud, 34570, France., Dallel R; NeuroDol INSERM 1107, Clermont-Ferrand, France., Delmas P; Centre de Recherche en CardioVasculaire et Nutrition, Aix-Marseille Université - INSERM 1263 -INRAE 1260, Marseille, France., Valmier J; Université de Montpellier, Montpellier, France. jean.valmier@umontpellier.fr.; Inserm U-1298, Institut des Neurosciences de Montpellier, Montpellier, France. jean.valmier@umontpellier.fr., Rivat C; Université de Montpellier, Montpellier, France. cyril.rivat@umontpellier.fr.; Inserm U-1298, Institut des Neurosciences de Montpellier, Montpellier, France. cyril.rivat@umontpellier.fr.
Publikováno v:
Nature communications [Nat Commun] 2024 Nov 07; Vol. 15 (1), pp. 9633. Date of Electronic Publication: 2024 Nov 07.
Autor:
Hesham HM; Pharmaceutical Chemistry Department, Faculty of Pharmacy, Ain Shams University, Abbassia, 11566, Cairo, Egypt., Dokla EME; Pharmaceutical Chemistry Department, Faculty of Pharmacy, Ain Shams University, Abbassia, 11566, Cairo, Egypt. Electronic address: emanelawady@pharma.asu.edu.eg., Elrazaz EZ; Pharmaceutical Chemistry Department, Faculty of Pharmacy, Ain Shams University, Abbassia, 11566, Cairo, Egypt., Lasheen DS; Pharmaceutical Chemistry Department, Faculty of Pharmacy, Ain Shams University, Abbassia, 11566, Cairo, Egypt., Abou El Ella DA; Pharmaceutical Chemistry Department, Faculty of Pharmacy, Ain Shams University, Abbassia, 11566, Cairo, Egypt. Electronic address: dalal@pharma.asu.edu.eg.
Publikováno v:
European journal of medicinal chemistry [Eur J Med Chem] 2024 Nov 05; Vol. 277, pp. 116717. Date of Electronic Publication: 2024 Aug 01.
Autor:
Chen J; Beijing Friendship Hospital, Capital Medical University, Beijing, China., Wu J; Beijing Friendship Hospital, Capital Medical University, Beijing, China., Guo N; CSPC Zhongqi Pharmaceutical Technology (SJZ) Co., Ltd., Shijiazhuang, Hebei Province, China., Song Y; Beijing Friendship Hospital, Capital Medical University, Beijing, China., Li L; Beijing Friendship Hospital, Capital Medical University, Beijing, China., Wang B; Beijing Friendship Hospital, Capital Medical University, Beijing, China., Li J; Beijing Friendship Hospital, Capital Medical University, Beijing, China., Hou M; Beijing Friendship Hospital, Capital Medical University, Beijing, China., Yin H; Beijing Friendship Hospital, Capital Medical University, Beijing, China., Zhang M; Beijing Friendship Hospital, Capital Medical University, Beijing, China., Kong Y; Beijing Friendship Hospital, Capital Medical University, Beijing, China., Wu X; Beijing Friendship Hospital, Capital Medical University, Beijing, China., Li R; Beijing Friendship Hospital, Capital Medical University, Beijing, China., Wu L; Beijing Friendship Hospital, Capital Medical University, Beijing, China., Gao Q; Beijing Friendship Hospital, Capital Medical University, Beijing, China., Dong R; Beijing Friendship Hospital, Capital Medical University, Beijing, China.
Publikováno v:
Clinical and translational science [Clin Transl Sci] 2024 Nov; Vol. 17 (11), pp. e70063.
Autor:
Vaddady P; Quantitative Clinical Pharmacology Department, Daiichi Sankyo, Inc., Basking Ridge, New Jersey, USA., Smania G; Pharmetheus AB, Uppsala, Sweden., Nakayama S; Quantitative Clinical Pharmacology Department, Daiichi Sankyo Co, Ltd., Tokyo, Japan., Inoue H; Quantitative Clinical Pharmacology Department, Daiichi Sankyo Co, Ltd., Tokyo, Japan., Kurumaddali A; Quantitative Clinical Pharmacology Department, Daiichi Sankyo, Inc., Basking Ridge, New Jersey, USA., Abutarif M; Quantitative Clinical Pharmacology Department, Daiichi Sankyo, Inc., Basking Ridge, New Jersey, USA., Zheng M; Quantitative Clinical Pharmacology Department, Daiichi Sankyo, Inc., Basking Ridge, New Jersey, USA.
Publikováno v:
Clinical and translational science [Clin Transl Sci] 2024 Nov; Vol. 17 (11), pp. e70065.
Autor:
Travaglini S; Department of Biomedicine and Prevention, University of Tor Vergata.; Department of Experimental Medicine, University of Rome Tor Vergata, Rome, Italy., Gurnari C; Department of Biomedicine and Prevention, University of Tor Vergata.; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio, USA., Ottone T; Department of Biomedicine and Prevention, University of Tor Vergata., Voso MT; Department of Biomedicine and Prevention, University of Tor Vergata.
Publikováno v:
Current opinion in oncology [Curr Opin Oncol] 2024 Nov 01; Vol. 36 (6), pp. 569-576. Date of Electronic Publication: 2024 Aug 26.
Autor:
Kennedy VE; Division of Hematology/Oncology, Department of Medicine, University of California San Francisco, 505 Parnassus Ave, Box 1270, San Francisco, CA, 94143, USA., Smith CC; Division of Hematology/Oncology, Department of Medicine, University of California San Francisco, 505 Parnassus Ave, Box 1270, San Francisco, CA, 94143, USA. catherine.smith@ucsf.edu.; Helen Diller Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. catherine.smith@ucsf.edu.
Publikováno v:
International journal of hematology [Int J Hematol] 2024 Nov; Vol. 120 (5), pp. 528-540. Date of Electronic Publication: 2023 Dec 19.
Autor:
Yu G; Department of Leukemia, Section of Molecular Hematology and Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China., Zhang W; Department of Leukemia, Section of Molecular Hematology and Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Basyal M; Department of Leukemia, Section of Molecular Hematology and Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Nishida Y; Department of Leukemia, Section of Molecular Hematology and Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Mizumo H; Department of Leukemia, Section of Molecular Hematology and Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Ly C; Department of Leukemia, Section of Molecular Hematology and Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Zhang H; Aptose Biosciences, San Diego, CA, USA., Rice WG; Aptose Biosciences, San Diego, CA, USA., Andreeff M; Department of Leukemia, Section of Molecular Hematology and Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Publikováno v:
Leukemia & lymphoma [Leuk Lymphoma] 2024 Nov; Vol. 65 (11), pp. 1659-1674. Date of Electronic Publication: 2024 Jun 13.
Autor:
Ansari AS; Department of Chemical and Materials Engineering, Faculty of Engineering, University of Alberta, Edmonton, Alberta, Canada., Kucharski C; Department of Chemical and Materials Engineering, Faculty of Engineering, University of Alberta, Edmonton, Alberta, Canada., Kc R; Department of Chemical and Materials Engineering, Faculty of Engineering, University of Alberta, Edmonton, Alberta, Canada., Nisakar D; Department of Chemical and Materials Engineering, Faculty of Engineering, University of Alberta, Edmonton, Alberta, Canada., Rahim R; Department of Chemical and Materials Engineering, Faculty of Engineering, University of Alberta, Edmonton, Alberta, Canada., Jiang X; Terry Fox Laboratory, BC Cancer Research Institute and Department of Medical Genetics, University of British Columbia, Vancouver, British Columbia, Canada., Brandwein J; Division of Hematology, Department of Medicine, Faculty of Medicine & Dentistry, University of Alberta, Edmonton, Alberta, Canada., Uludağ H; Department of Chemical and Materials Engineering, Faculty of Engineering, University of Alberta, Edmonton, Alberta, Canada; Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Alberta, Canada. Electronic address: huludag@ualberta.ca.
Publikováno v:
Acta biomaterialia [Acta Biomater] 2024 Oct 15; Vol. 188, pp. 297-314. Date of Electronic Publication: 2024 Sep 03.